Basic Information
| LncRNA/CircRNA Name | circPCNX |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | liver cancer |
| ICD-0-3 | C22.0 |
| Methods | qPCR, CCK8 assay, colony formation assay and cell apoptosis assay, western blotting |
| Sample | liver cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | We observed that circPCNX and Pecanex were significantly upregulated in tumor tissues of patients with HCC and correlated with clinicopathological variables or prognosis of HCC patients. |
| Pubmed ID | 32099459 |
| Year | 2020 |
| Title | circPCNX and Pecanex Promote Hepatocellular Carcinoma Cell Viability by Inhibiting miR-506 |
External Links
| Links for circPCNX | GenBank HGNC NONCODE |
| Links for liver cancer | OMIM COSMIC |